Respiratory Trials·org

Sepsis & septic shock · How much fluid

CLOVERS randomised trial

Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension

CLOVERS trial design and results
Design Multicentre randomised controlled trial
Treatment Restrictive fluid strategy with earlier vasopressor use
Control Liberal fluid strategy
Population 1563 patients with sepsis-induced hypotension
Follow-up 90 days
Primary endpoint Death from any cause before discharge home by day 90
Result 782 patients were assigned to restrictive fluids and 781 to liberal fluids. Resuscitation therapies during the 24-hour protocol period differed clearly between the groups, with no significant difference in mortality before discharge home by day 90.
Secondary endpoints Ventilator-free days, vasopressor-free days, renal replacement therapy

Among patients with sepsis-induced hypotension, the restrictive fluid strategy that was used in this trial did not result in significantly lower (or higher) mortality before discharge home by day 90 than the liberal fluid strategy.

The trial authors, in the published abstract

How it has aged

The authors' parenthetical — 'or higher' — is the point. Within the ranges these trials tested, fluid strategy simply does not determine survival, and clinicians can reasonably individualise. Concordant with CLASSIC later in the illness.

Publications

Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension

Shapiro NI, Douglas IS, Brower RG, et al. Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension. N Engl J Med 2023 Feb 9;388(6):499-510.

  • No difference in mortality before discharge home by day 90
  • Substantially different fluid and vasopressor use between arms